Do You Really (Really?) Need Machine Learning for Prospecting? When was the last time you read a press release about a new biopharma and headed straight to PubMed to investigate their research? Maybe you did a quick keyword search to understand how they’re using...
Selling into early-stage research is critical to having your technology, products, or services embedded in a new disease or drug research program. Still, unless you have all the right connections at thousands of organizations (or a crystal ball!), identifying those...
Traditional lead gen is poorly suited to Life Sciences marketing and sales Traditional marketing approaches rely heavily on generating a large number of marketing leads, then spending months on nurturing campaigns with broad reach and spend. Once these campaigns have...
As of 2018, more than 3,200 Emerging Biopharma (EBP) companies—characterized by R&D spend of less than $200 million or prescription sales up to $500 million—have an active R&D drug pipeline. Of the 8,700 products or programs in active development, ranging from...
Account-based marketing. It’s all the rage. Most B2B commercial teams are at least thinking of implementing account-based marketing (ABM) programs if they haven’t already. But why is it a must-have for life science sales and marketing teams? What exactly is ABM? Our...
Most of us welcomed 2020 with our sights set on new achievements, only to have our business activities and life as we know it significantly disrupted by the COVID-19 crisis. While sheltering in place is a crucial step to save lives, disruptions to networking and...
The COVID-19 pandemic has created so many difficult challenges for the world. Thankfully, the life science community has risen and continues to rise to meet some of the most pressing of these, bringing the collective brilliance and innovative thinking of diverse...
To our esteemed colleagues around the globe: The COVID-19 pandemic is going to get worse before it gets better, so the medical statistics demonstrate. At this point, it has already required us to adapt to social distancing and caused us all to reevaluate how we work...
Amplion’s Machine Learning Platform Accelerates Precision Medicine Collaboration Dx:Revenue™ solution rapidly identifies and qualifies drug and test developer partnership opportunities Effective partnerships between pharmaceutical companies, biotechs, academia,...
Seattle’s annual GeekWire Summit brings together thousands of tech and business leaders for a conversation about the future. This year, organizers are hosting a panel discussion on The Quest for Personalized Medicine that will include Dr. Amanda Enstrom, Amplion’s...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Real-Time COVID R&D Tracking
As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today. Learn More
